Showing results (21-30 of 109) with videos related to

Sort By:
Pageof 11
Pharmacology & Therapeutics|September 27, 2005
Interfering with the brain: use of RNA interference for understanding the pathophysiology of psychiatric and neurological disordersDeepak R Thakker, Daniel Hoyer, John F Cryan
Pharmaceutical Research|March 6, 1998
Modulation of the tight junctions of the Caco-2 cell monolayers by H2-antagonistsL S Gan, S Yanni, D R Thakker
Molecular Pharmaceutics|July 26, 2011
Vectorial transport of fexofenadine across Caco-2 cells: involvement of apical uptake and basolateral efflux transportersXin Ming, Beverly M Knight, Dhiren R Thakker
The Journal of Pharmacology and Experimental Therapeutics|January 23, 2003
Role of phospholipase C-beta in the modulation of epithelial tight junction permeabilityPeter D Ward, Hui Ouyang, Dhiren R Thakker
Biochemical Society Transactions|March 21, 2007
Emerging use of non-viral RNA interference in the brainJ F Cryan, D R Thakker, D Hoyer
The Journal of Pharmacology and Experimental Therapeutics|May 17, 2003
Mu-opioid-induced desensitization of opioid receptor-like 1 and mu-opioid receptors: differential intracellular signaling determines receptor sensitivityChitra D Mandyam, Deepak R Thakker, Kelly M Standifer
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 7, 2008
Mechanisms underlying saturable intestinal absorption of metforminWilliam R Proctor, David L Bourdet, Dhiren R Thakker
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 4, 2013
Intestinal first-pass metabolism by cytochrome p450 and not p-glycoprotein is the major barrier to amprenavir absorptionMatthew B Dufek, Arlene S Bridges, Dhiren R Thakker
Pageof 11